Investigator-initiated observational cohort study aimed to assess the cardiovascular safety of amphetamines, methylphenidate, and atomoxetine, commonly-used medications for the treatment of patients with attention-deficit hyperactivity disorder

Trial Profile

Investigator-initiated observational cohort study aimed to assess the cardiovascular safety of amphetamines, methylphenidate, and atomoxetine, commonly-used medications for the treatment of patients with attention-deficit hyperactivity disorder

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2010

At a glance

  • Drugs Amphetamines; Atomoxetine; Methylphenidate
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top